Announced Thu, 29 Jan · 18:44 IST

Resignation of Statutory Auditor

Auditor Resigned MidtermManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

M/s. Doshi Doshi & Co, Chartered Accountants (FRN: 153683W) has resigned as the statutory auditor of Asston Pharmaceuticals Ltd, effective January 28, 2026. The auditor cited preoccupation with other assignments and inability to devote adequate time as the reason, with no concerns raised about the company's management. The firm was originally appointed on September 30, 2024, for a 5-year term ending at the 2029 AGM, making this a mid-term exit roughly 1.5 years into the tenure. The auditor had already completed the limited review of half-yearly financials ending September 30, 2025. The company's Audit Committee and Board will appoint a new statutory auditor to fill the casual vacancy.

Likely market impact

The reason for resignation is benign and routine, with no governance red flags or management-related concerns flagged by the outgoing auditor. Shareholders should watch for the announcement of a new auditor appointment; an orderly transition should have no material impact on the stock, though any delay in appointing a replacement could affect audit timelines.